Featured series 
Tag: American Cancer Society
-
Nation & World
Years after cancer treatment, sleepless nights
Researchers found that 51 percent of cancer survivors surveyed experienced sleep disturbances.
-
Nation & World
Seeking a culprit behind rise in colorectal cancer among younger adults
Kimmie Ng, a Dana-Farber physician-researcher, answers questions on possible factors driving an increase in colon cancer among young adults.
-
Nation & World
A deadly foe
By the end of the conference, “Governance of Tobacco in the 21st Century,” a few recommendations for international controls stood out: Consider public health a basic human right, and tobacco promotion a violation of that right.
-
Nation & World
New subtype of ovarian cancer identified
Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to “anti-angiogenic” drugs that block blood vessel formation
-
Nation & World
Right time for ‘end-of-life’ talk
A study by Harvard-affiliated Dana-Farber Cancer Institute finds that most terminally ill cancer patients discuss end-of-life care with physicians but that such discussions often occur late in their illness.
-
Nation & World
Bunches of support
Harvard’s 25th annual Daffodil Days campaign to help raise money for the American Cancer Society is under way through March 1, with gifts scheduled for delivery on March 19.
-
Nation & World
Colon cancer connection
Scientists at Harvard-afilliated Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
-
Nation & World
Disrupting a cancer gene
Scientists at Harvard-affiliated Dana-Farber Cancer Institute have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene’s “on” switch and growth signals, rather than targeting the gene itself.
-
Nation & World
What’s behind aggressive breast cancer
Harvard scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.
-
Nation & World
Daffodil Days are here again
Members of the Harvard community are invited to purchase fresh bouquets of daffodils for $10 to support the research and programs of the American Cancer Society. The deadline to order is March 1.
-
Nation & World
Better odds
Test could predict which children with T-cell acute lymphoblastic leukemia are best candidates for clinical trials of new therapies, research finds.
